Nootropic

product on market Capsule Alani Nu Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines caffeine and citicoline, which have strong evidence for enhancing alertness and cognitive function. Lion's mane and huperzia serrata are included for neuroprotective and memory support, though research on these specific extracts is more limited. Methylliberine is utilized to modulate the stimulant effects of caffeine.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Nootropic
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Veggie Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Lion's Mane Mushroom powder
500 mg
Within RDA (0.5× RDA) 38 studies (A:1, B:7)
80 mg
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)
Methylliberine
25 mg
Market median: 0.15mg (41 products)

Other Ingredients

Hypromellose Ascorbyl Palmitate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take two capsules daily preferably with a light meal.

Warnings & Precautions

Warning: Do not use if you are under 18 years of age.

If you have any medical condition or you are currently using prescription medications, please consult your physician before taking this or any other dietary supplements.

Keep out of reach of children.

Allergen Warning: Processed in a facility and/or manufacturing line that also processes products containing milk, eggs, soybeans, wheat, shellfish, fish oil, tree nuts, and peanut flavor.

Formulation Notes

Vegan

Gluten-free

Mood Focus Cognition Motivation

Additional Information

Store in a cool, dry place.

GMP Good Manufacturing Practice

Metadata

Product Details

UPC / SKU8 10030 51047 5
DSLD Entry Date2021-01-22
Product TypeOther Combinations
FormCapsule
DSLD ID242727
Data Updated2026-04-11
Research

Research Evidence

2
Research Sources
64
Avg Quality
2
Cochrane Review
B Huperzine A for vascular dementia.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Huperzine A for mild cognitive impairment.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
View all evidence for Huperzine A →
Compare

Similar Products

View all Huperzine A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.